Coronary Stents Market is Expected to Grow at a CAGR of 7.50% and is Anticipated to Reach USD 10.97 Billion by 2026, Estimates DelveInsight
Coronary Stents Market is Expected to Grow at a CAGR of 7.50% and is Anticipated to Reach USD 10.97 Billion by 2026, Estimates DelveInsight
LAS VEGAS, Nov. 23, 2021 /PRNewswire/ -- DelveInsight's Coronary Stents Market Insights and Forecast report provides the current and forecast Coronary Stents market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Coronary Stents market.
拉斯維加斯，2021年11月23日/美通社/--DelveInsight的冠狀動脈支架市場洞察與預測該報告提供了冠狀動脈支架市場的現狀和預測、即將到來的設備創新、單個市場份額、挑戰、驅動因素和障礙、市場趨勢以及冠狀動脈支架市場的主要競爭對手。
Some of the salient features from the Coronary Stents Market report:
中的一些顯著特徵冠狀動脈支架市場報告：
- As per an analysis by DelveInsight, North America is expected to dominate the overall Coronary Stents market during the forecast period.
- Major pharma players working proactively in the Coronary Stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.
- DelveInsight estimates that global Coronary Stents market was valued at USD 8.65 billion in 2020, growing at a CAGR of 7.50% during the forecast period from 2021 to 2026, to reach USD 10.97 billion by 2026.
- In September 2021, BIOTRONIK received the US Food and Drug Administration (FDA) approval for its Orsiro® Mission bioabsorbable polymer drug-eluting stent system (BP-DES).
- In August 2020, Boston Scientific Corporation received FDA approval for its SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail and Over-The-Wire).
- 根據DelveInsight的分析，北美預計在預測期內將主導整個冠狀動脈支架市場。
- 在冠狀動脈支架市場積極工作的主要製藥公司包括美敦力公司、雅培公司、波士頓科學公司、生物傳感器國際集團有限公司、BIOTRONIK SE&Co.KG公司、B.Braun Melsungen股份公司、Terumo公司、Stentys SA公司、微創醫療(一百)公司、梅里爾生命科學私人有限公司、BIOTRONIK SE&Co.KG公司、B.Braun Melsungen AG公司、Terumo公司、Stentys SA公司、微創醫療(一百)公司還有其他人。
- DelveInsight估計，全球冠狀動脈支架市場的估值為86.5億美元2020年，將以複合年增長率為7.50%在2021年至2026年的預測期內，將達到1美元109.7億到2026年。
- 在……裏面2021年9月，BIOTRONIK獲得了美國食品和藥物管理局(FDA)的批准Orsiro®Task生物可吸收聚合物藥物洗脱支架系統(BP-DES)。
- 在……裏面2020年8月、波士頓科學公司獲得美國食品和藥物管理局(FDA)的批准協同Everolimus-洗脱鉑鉻冠狀動脈支架系統(單軌和有線)。
Interested in knowing how the Coronary Stents Market will be growing by 2026? Click to get a snapshot of Coronary Stents Market Analysis
想知道到2026年冠狀動脈支架市場將如何增長嗎？單擊以獲取以下內容的快照冠狀動脈支架市場分析
Coronary Stents Overview
冠狀動脈支架概述
Coronary Stents are expandable tubular metallic devices. These are introduced into the coronary arteries that show stenosis caused by an atherosclerosis disease. It is required during a procedure called percutaneous coronary intervention (PCI) or angioplasty. It is a tiny, expandable metal mesh coil, inserted into the newly opened area of the artery to support the artery from narrowing or closing again. The stent is covered by tissue within 3 to 12 months, depending on if the stent has a medicine coating or not. Stents can aid in the reduction of recurrent blockage or narrowing after an angioplasty procedure. Once the stent is implanted, it will remain in your artery permanently. Types of Coronary Stents includes: Bare metal stents (BMS), Drug-eluting stents (DES), Bioresorbable scaffold system (BRS), and Drug-eluting balloons (DEB). Technical improvements in stent placement and the development of drug-eluting stents (DES) led to greater use of PCI.
冠狀動脈支架是一種可膨脹的管狀金屬裝置。它們被引入冠狀動脈，顯示由動脈粥樣硬化疾病引起的狹窄。這在稱為經皮冠狀動脈介入(PCI)或血管成形術的過程中是必需的。它是一種微小的、可擴展的金屬網狀線圈，插入動脈新開放的區域，以支持動脈不再狹窄或再次閉合。支架在3到12個月內被組織覆蓋，這取決於支架是否有藥物塗層。支架有助於減少血管成形術後復發的阻塞或狹窄。一旦支架被植入，它將永久留在你的動脈中。冠狀動脈支架的類型包括：裸金屬支架(BMS)、藥物洗脱支架(DES)、生物可吸收支架系統(BRS)、和藥物洗脱氣球(DEB)。支架置入技術的改進和藥物洗脱支架(DES)的發展使PCI得到了更廣泛的應用。
To pick on the latest highlights related to Coronary Stents, get the snapshot of the key highlights entailed in the Coronary Stents Market report.
要了解與冠狀動脈支架相關的最新亮點，請獲取冠狀動脈支架市場報告情況。
Coronary Stents Market Insight
冠狀動脈支架市場透視
Geographically, the global Coronary Stents market is studied for North America, Europe, Asia- Pacific, and Rest of the World. In terms of revenue share North America currently leads the global market and is expected that it will remain constant during the forecast period. This domination is observed majorly due to the growing cases of neurologic disorders, rising healthcare expenditure due to strong economy, and presence of well- established healthcare infrastructure.
在地理上，全球冠狀動脈支架市場是針對北美進行研究的，歐洲、亞太地區和世界其他地區。在收入份額方面北美目前引領全球市場，預計在預測期內將保持不變。觀察到這種主導地位的主要原因是神經疾病病例不斷增加，強勁的經濟導致醫療支出增加，以及成熟的醫療基礎設施的存在。
According to DelveInsight estimates, the drug eluting stent is expected to hold the largest market share in 2020 which will remain constant during the forecast period. This is owing to the various advantages of drug eluting stents over bare metal stents and others. Drug eluting stents are more effective in the prevention of restenosis than the use of bare-metal stents, the use of newer-generation drug-eluting stents also reduce the rate of stent thrombosis and myocardial infarction.
據DelveInsight估計，藥物洗脱支架預計將在2020年佔據最大的市場份額，這一份額在預測期內將保持不變。這是由於藥物洗脱支架比裸金屬支架和其他支架有許多優點。藥物洗脱支架在預防再狹窄方面比裸金屬支架更有效，新一代藥物洗脱支架的使用也降低了支架血栓形成和心肌梗死的發生率。
The launch of new innovative devices will also lead to an increase in the Coronary Stents market growth. For instance, in October 2021, CytoSorbents Corporation announced that the first patient has been enrolled in the Safe and Timely Antithrombotic Removal-Ticagrelor (STAR–T) double-blind, randomized, controlled clinical trial designed to support FDA marketing approval of the DrugSorb-ATR™ Antithrombotic Removal System for intraoperative removal of ticagrelor during cardiothoracic surgery. In October 2020, Biosensors received the CE Mark for BioFreedomUltra, new drug coated coronary stent system with thin strut (84µm) CoCr polymer and Biosensors' Biolimus A9 drug.
新的創新設備的推出也將導致冠狀動脈支架市場增長的增加。例如，在2021年10月、CytoSorbents公司宣佈首例患者已登記參加安全、及時的抗血栓藥物取出器-替加瑞爾(STAR-T)旨在支持FDA上市批准的雙盲、隨機、對照臨牀試驗DrugSorb-ATR™抗血栓清除系統用於心胸外科手術中摘除膝蓋肌。在……裏面2020年10月、生物傳感器榮獲CE標誌BioFreedomUltra新的藥物塗層冠狀動脈支架系統採用薄支柱(84µm)CoCr聚合物和Biosensors的Biolimus A9藥物。
To know more why North America is leading the market growth in Coronary Stents market, get a snapshot of report Coronary Stents Market Assessment
要了解更多為什麼北美引領冠狀動脈支架市場增長的原因，請瀏覽報告快照冠狀動脈支架市場評估
Coronary Stents Market Drivers and Barriers
冠狀動脈支架市場的驅動因素和障礙
Owing to the rise in the number of cardiovascular disorder cases, growing burden of old age population susceptible to various cardiovascular disorders, shifting preferences towards minimally invasive surgeries, technological advancement in the product line, there will be a rapid growth observed in Coronary Stents market during the forecast period. In addition to that, presence of key manufacturers such as Medtronic, Boston Scientific Corporation, and recent product approvals is also likely to boost the Coronary Stents market.
由於心血管疾病的數量上升案件，老齡化人口負擔日益加重容易患上各種心血管疾病，將偏好轉向微創手術，產品線的技術進步，在預測期間，冠狀動脈支架市場將出現快速增長。句號。除此之外，還有主要製造商比如美敦力，波士頓科學公司，和最近的產品審批這也可能提振冠狀動脈支架市場。
The demand for Coronary Stents is highly affected by the outbreak of the COVID-19 pandemic because of the delay in surgeries needed for the implantation of Coronary Stents. The excessive inflammatory response and hypercoagulable state associated with coronavirus disease (COVID-19) might trigger acute coronary events or stent thrombosis. However, cases of stent thrombosis directly associated with COVID-19 have not been reported.
對冠脈支架的需求受經濟形勢的影響很大。新冠肺炎大流行爆發因為手術的延誤冠狀動脈支架植入術所需的藥物。與冠狀病毒病(新冠肺炎)相關的過度炎症反應和高凝狀態可能引發急性冠狀動脈事件或者支架血栓。然而，與新冠肺炎直接相關的支架血栓形成的病例還沒有報道。
To get a deeper understanding of the driving factors related to the Coronary Stents market, get a snapshot of the Coronary Stents Market Dynamics
要更深入地瞭解與冠狀動脈支架市場相關的驅動因素，請快速瞭解冠狀動脈支架市場動態
Scope of the Coronary Stents Market Report
的範圍冠狀動脈支架市場報告
Study Period: 2018-2026
學習期間：2018-2026
Key Companies: Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.
主要公司：美敦力、雅培、波士頓科學公司、生物傳感器國際集團有限公司、BIOTRONIK SE&Co.KG、B.Braun Melsungen AG、Terumo Corporation、Stentys SA、微創醫療(一百)、美利生命科學私人有限公司等。
Coronary Stents Market Segmentation
冠狀動脈支架市場細分
By Product Type
按產品類型
- Bare Metal Stents
- Drug Eluting Stents
- Bioresorbable Scaffolds
- 裸金屬支架
- 藥物洗脱支架
- 生物可吸收支架
By Material
按材質
- Metal
- Stainless Steel
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Polymers
- 金屬
- 不鏽鋼
- 鈷鉻
- 鉑鉻
- 鎳醇
- 高聚物
By End-User
按最終用户
- Hospitals
- Ambulatory Surgical Centres
- Others
- 醫院
- 門診外科中心
- 其他
By Geography
按地理位置劃分
- North America
- Europe
- Asia-Pacific
- Rest of World
- 北美
- 歐洲
- 亞太
- 世界其他地區
Delveinsight Analysis: The Coronary Stents market is expected to grow at a CAGR of 7.50% during the forecast period from 2021 to 2026, to reach USD 10.97 billion by 2026.
DelveInsight分析：從2021年到2026年，冠狀動脈支架市場預計將以7.50%的複合年增長率增長，到2026年將達到109.7億美元。
Table of Contents
目錄
|
1 |
Coronary Stents Market Report Introduction |
|
2 |
Coronary Stents Market Executive summary |
|
3 |
Regulatory and Patent Analysis |
|
4 |
Coronary Stents Market Key factors analysis |
|
5 |
Coronary Stents Porter's Five Forces Analysis |
|
6 |
COVID-19 Impact Analysis on Coronary StentsMarket |
|
7 |
Coronary Stents Market Layout |
|
8 |
Coronary Stents Global Company Share Analysis – Key 3-5 Companies |
|
9 |
Coronary Stents Market Company and Product Profiles |
|
9.1 Medtronic 9.2 Boston Scientific Corporation 9.3 Abbott 9.4 Biosensors International Group, Ltd. 9.5 BIOTRONIK 9.6 B. Braun Melsungen AG 9.7 Terumo Corporation 9.8 STENTYS SA 9.9 MicroPort Scientific Corporation 9.10 Meril Life Sciences Pvt. Ltd. 9.11 Vascular Concepts 9.12 COOK 9.13 SCITECH Medical 9.14 Lepu Medical Technology Co.,Ltd. 9.15 OrbusNeich Medical Company Limited | |
|
10 |
Project Approach |
|
11 |
KOL Views |
|
12 |
DelveInsight Capabilities |
|
13 |
Disclaimer |
|
14 |
About DelveInsight |
|
1 |
冠狀動脈支架市場報告簡介 |
|
2 |
冠狀動脈支架市場執行摘要 |
|
3 |
法規和專利分析 |
|
4 |
冠狀動脈支架市場關鍵因素分析 |
|
5 |
冠狀動脈支架波特的五力分析 |
|
6 |
新冠肺炎對冠狀動脈支架市場的影響分析 |
|
7 |
冠狀動脈支架市場佈局 |
|
8 |
冠脈支架全球公司份額分析--主要3-5家公司 |
|
9 |
冠狀動脈支架市場公司及產品簡介 |
|
9.1美敦力 9.2波士頓科學公司 9.3雅培 9.4生物傳感器國際集團有限公司 9.5 BIOTRONIK 9.6B.Braun Melsungen AG 9.7Terumo公司 9.8 Stentys SA 9.9微創醫療(一百) 9.10梅里爾生命科學私人有限公司 9.11血管概念 9.12廚師 9.13科技醫療 9.14樂普醫療科技有限公司 9.15 OrbusNeich醫療有限公司 | |
|
10 |
項目法 |
|
11 |
KOL視圖 |
|
12 |
DelveInsight功能 |
|
13 |
免責 |
|
14 |
關於DelveInsight |
Learn more about the report offerings @ Coronary Stents Market Outlook
瞭解有關報告產品的更多信息@ 冠狀動脈支架市場展望
Understand the Competition, Risk Assessment and effective Research and Development approach to take value-based decisions.
瞭解競爭、風險評估和有效性研究與開發採取基於價值的決策的方法。
Related Reports
相關報告
Coronary Stents Pipeline
冠狀動脈支架管道
DelveInsight's, "Coronary Stents – Pipeline Insight and Competitive Landscape, 2021," report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape which include companies like Rontis AG, S3V Vascular Technologies, Sahajanand Medical Technologies Pvt Ltd, Shanghai Bio-heart Biological Technology Co Ltd, Stentys SA, Svelte Medical Systems Inc, Tepha Inc, Terumo Corp, TissueGen Inc, TrendyMED Inc, VasoTech Inc, Viller Scientific LLC, Vornia Biomaterials Ltd, Xenogenics Corporation, Biotronik AG, and others.
DelveInsight的冠狀動脈支架-管道洞察和競爭格局，2021年，這份報告提供了關於冠狀動脈支架管道領域的20多家公司和20多個管道設備的全面見解，其中包括羅蒂斯股份公司、S3V血管技術公司、Sahajanand Medical Technologies PVT有限公司、百心安-B技術有限公司、Stentys SA、Svelte Medical Systems Inc.、Tepha Inc.、Terumo Corp、TisseGen Inc.、TrendyMED Inc.、VasoTech Inc.、Viller Science LLC、沃尼亞生物材料有限公司、Xengenics Corporation、Biotronik AG，以及其他。
Vascular Stents market
血管支架市場
DelveInsight's 'Vascular Stents - Market Insights, Competitive Landscape and Market Forecast–2026' report delivers an in-depth understanding of Vascular Stents and the historical and forecasted Vascular Stents market trends, market drivers, market barriers and key companies involved such as Medtronic, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation, W. L. Gore and Associates, C. R. Bard, Endologix, Lombard Medical Technologies, and others.
DelveInsight的血管支架-市場洞察、競爭格局和市場預測-2026年該報告深入瞭解了血管支架以及血管支架的歷史和預測市場趨勢、市場驅動因素、市場障礙和涉及的主要公司，如首頁--期刊主要分類--期刊細介紹--期刊題錄與文摘--期刊詳細文摘內容還有其他人。
Urinary Stents Market
尿路支架市場
DelveInsight's 'Urinary Stents -Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Urinary Stents and the historical and forecasted Urinary Stents market trends, market drivers, market barriers and key companies involved such as Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, C. R. Bard, Coloplast Ltd., Medline Industries, Allium Medical Solutions Ltd, Pnn Medical A/S, Teleflex Incorporated, Olympus Corporation, GBUK Healthcare Ltd, Red Leaf Medical, Dextronix, and several others.
DelveInsight的尿路支架-市場洞察、競爭格局和市場預測-2026年該報告深入瞭解了尿路支架以及尿路支架的歷史和預測市場趨勢、市場驅動因素、市場障礙和涉及的主要公司，如波士頓科學公司、B.Braun Holding GmbH&Co.KG公司、庫克集團公司、C.R.巴德公司、Colplast有限公司、Medline工業公司、Allium醫療解決方案有限公司、PNN Medical A/S公司、Teleflex公司、奧林巴斯公司、GBUK Healthcare Ltd、紅葉醫療公司、德事隆公司，以及其他幾個。
Drug-Eluting Stents Market
藥物洗脱支架市場
DelveInsight's 'Drug-Eluting Stents - Market Insights, Competitive Landscape and Market Forecast–2026' report delivers an in-depth understanding of Drug-Eluting Stents and the historical and forecasted Drug-Eluting Stents market trends, market drivers, market barriers and key companies involved such as Abbott, Braun Melsungen AG, Biosensors International Group, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, STENTYS SA, Lepu Medical, Cook, Cardinal Health, and others.
DelveInsight的藥物洗脱支架-市場洞察、競爭格局和市場預測-2026年報告深入瞭解藥物洗脱支架以及藥物洗脱支架的歷史和預測市場趨勢、市場驅動因素、市場障礙和涉及的主要公司，如雅培公司、Braun Melsungen股份公司、生物傳感器國際集團、BIOTRONIK SE&Co.kg公司、波士頓科學公司、Terumo公司、美敦力公司、微創醫療(一百)公司、Stentys SA公司、樂普醫療公司、庫克公司、紅衣主教健康公司還有其他人。
Biliary Stents Market
膽道支架市場
DelveInsight's 'Biliary Stents Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of biliary stents and the historical and forecasted biliary stents market trends, market drivers, market barriers and key companies involved such as Abbot Laboratories, Boston Scientific, Medi-Globe, Bard Medical, Cook India Medical Devices Pvt, Medtronic, Merit Medical Systems, Endocor, InSitu Technologies, and others.
DelveInsight的“膽道支架市場洞察、競爭格局和市場預測-2026年”報告深入瞭解膽道支架以及膽道支架的歷史和預測市場趨勢、市場驅動因素、市場障礙和涉及的主要公司，如阿博特實驗室，波士頓科學公司，Medi-Globe公司，巴德醫療公司，庫克印度醫療設備公司，美敦力公司，Merit醫療系統公司，Endocor，Insite Technologies，還有其他人。
Carotid Artery Stent Market
頸動脈支架市場
DelveInsight's 'Carotid Artery Stent Market - Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of Carotid Artery Stent Carotid Artery Stent and the historical and forecasted Carotid Artery Stent market trends, market drivers, market barriers and key companies involved such as Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Johnson & Johnson, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, BIOTRONIK SE & Co. KG, InspireMD, Contego Medical, Impulse Dynamics, and others.
DelveInsight的頸動脈支架市場-市場洞察、競爭格局和市場預測-2026年這份報告深入瞭解了頸動脈支架以及頸動脈支架的歷史和預測市場趨勢、市場驅動因素、市場障礙和涉及的主要公司，如首頁--期刊主要分類--期刊細介紹--期刊題錄與文摘--期刊詳細文摘內容還有其他人。
Browse Through Our Blog Posts
瀏覽我們的博客帖子
- Evaluating the Role of Digital Therapeutics as an Alternative to Conventional Therapies for Depression
- Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation
- MedTech Industry Roars Back as FDA Approvals Soar
- 評估數字治療學作為抑鬱症傳統療法的替代療法
- 醫療器械市場關鍵的MedTech公司繼續引入創新，蓬勃發展
- 醫療技術產業FDA批准數量飆升，呼聲回升
Connect With Us at LinkedIn | Facebook | Twitter
在LinkedIn上與我們聯繫 |臉譜 |推特
Contact Us
聯繫我們
Shruti Thakur
[email protected]
+1(919)321-6187
www.delveinsight.com
Shruti Thakur
[受電子郵件保護]
+1(919)321-6187
Www.delveinsight.com
SOURCE DelveInsight Business Research, LLP
來源：DelveInsight Business Research，LLP